Aligning Science Across Parkinson's Logo Text

PD-RISK Index: Piloting an unsupervised toolkit to identify adults with Parkinson disease

Output Details

Effective screening for Parkinson disease (PD) is important for symptom management and patient recruitment into disease-modifying trials. Here, we examined the performance of the PD-RISK Index toolkit in identifying PD patients at home without supervision. Between 2022-2024, we recruited 305 participants (ages, 40–85 years): 93 with typical PD; 66 had other neurological conditions; and 146 were healthy controls. Two versions of the toolkit were completed: An original, 69-item-long questionnaire with the 40-scent University-of-Pennsylvania-Smell-Identification-Test (UPSIT); thereafter, a simplified, 11- item-short questionnaire with a newly-developed 8-scent smell test and responses submitted online. The corresponding summary scores (‘PD-RISK Indices’) were calculated for each subject to evaluate diagnostic performances. In both versions, PD patients had higher questionnaire scores and worse olfaction than healthy controls (*P<0.001*), as expected; scores for subjects with other neurological conditions ranked at intermediate levels. The simplified 11-item questionnaire outperformed the original version in identifying PD. The abbreviated 8-scent smell test and the UPSIT booklet performed equally well in detecting hyposmia. The simplified PD-RISK Index showed the highest diagnostic performance in identifying PD patients amongst all participants; at a value of 23 (range, 0–100, where higher scores indicate higher PD risk), we measured a sensitivity of 0.98, specificity of 0.83, and positive and negative likelihood ratios of 5.88 and 0.02, respectively. The simplified ‘PD-RISK Index’ showed stable performance across sexes and disease duration. Our study reveals that unsupervised screening for manifest PD can be effectively carried out at home using an 11-item questionnaire, 8-scent smell test and online data entry.
Tags
  • Diagnostic
  • Disease risks
  • Olfaction
  • Olfactory dysfunction
  • PD risks
  • Predictive models

Meet the Authors

  • User avatar fallback logo

    Juan Li

    External Collaborator

  • User avatar fallback logo

    Kelsey Grimes

    External Collaborator

  • User avatar fallback logo

    Joseph Saade

    External Collaborator

  • User avatar fallback logo

    David Lewis

    External Collaborator

  • Julianna Tomlinson, PhD

    Project Manager: Team Schlossmacher, 

    Ottawa Hospital

  • User avatar fallback logo

    aSCENT-PD Investigators

    External Collaborator

  • User avatar fallback logo

    Andrew Frank

    External Collaborator

  • User avatar fallback logo

    Tim Ramsay

    External Collaborator

  • User avatar fallback logo

    Natalina Salmaso

    External Collaborator

  • User avatar fallback logo

    Douglas Manuel

    External Collaborator

  • Michael Schlossmacher, MD

    Lead PI (Core Leadership): Team Schlossmacher, 

    The Ottawa Hospital

Aligning Science Across Parkinson's
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.